Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by wyndeweston Aug 02, 2021 8:10pm
63 Views
Post# 33640767

RE:Price Waterhouse Cooper ( disclamer)

RE:Price Waterhouse Cooper ( disclamer)Thank you 4Justice for posting the Price Waterhouse statement..  This is very interesting and I would think damaging for Thomvest (defendents).  
2 questions: 1. I didn't see a date that it was written? 2. do you have an idea of the accounting practices they changed in 2019?  That statement by PW sounds ominous (not positive for Liminal)
<< Previous
Bullboard Posts
Next >>